Skip to content
10-K/A

Annual Report

21st Century Oncology Holdings, Inc.

0001047469-16-015098

← back to feed
Filed
Aug 23, 2016 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Aug 23, 2016 1.06K sh
Capex restated FY 2014 · Dec 31, 2014 $56.66M
Capex restated FY 2014 · Dec 31, 2013 $40.65M
Capex restated FY 2014 · Dec 31, 2012 $30.64M
Cash And Equivalents restated FY 2014 · Dec 31, 2014 $99.08M
Cash And Equivalents FY 2014 · Sep 30, 2014 $160.49M
Cash And Equivalents FY 2014 · Jun 30, 2014 $25.45M
Cash And Equivalents FY 2014 · Mar 31, 2014 $11.97M
Cash And Equivalents restated FY 2014 · Dec 31, 2013 $17.13M
Cash And Equivalents FY 2014 · Sep 30, 2013 $32.12M
Cash And Equivalents FY 2014 · Jun 30, 2013 $11.33M
Cash And Equivalents FY 2014 · Mar 31, 2013 $10.39M
Cash And Equivalents restated FY 2014 · Dec 31, 2012 $15.08M
Cash And Equivalents restated FY 2014 · Dec 31, 2011 $9.85M
Stockholders Equity restated FY 2014 · Dec 31, 2014 −$493.44M
Stockholders Equity FY 2014 · Sep 30, 2014 −$449.53M
Stockholders Equity FY 2014 · Jun 30, 2014 −$359.02M
Stockholders Equity FY 2014 · Mar 31, 2014 −$148.11M
Stockholders Equity restated FY 2014 · Dec 31, 2013 −$109.38M
Stockholders Equity FY 2014 · Sep 30, 2013 −$86.76M
Stockholders Equity FY 2014 · Jun 30, 2013 −$53.56M
Stockholders Equity FY 2014 · Mar 31, 2013 −$29.74M
Current Liabilities restated FY 2014 · Dec 31, 2014 $198.73M
Current Liabilities FY 2014 · Sep 30, 2014 $231.34M
Current Liabilities FY 2014 · Jun 30, 2014 $234.46M
Current Liabilities FY 2014 · Mar 31, 2014 $221.37M
Current Liabilities restated FY 2014 · Dec 31, 2013 $154.93M
Current Liabilities FY 2014 · Sep 30, 2013 $124.21M
Current Liabilities FY 2014 · Jun 30, 2013 $110.26M
Current Liabilities FY 2014 · Mar 31, 2013 $117.62M
Total Liabilities restated FY 2014 · Dec 31, 2014 $1.26B
Total Liabilities FY 2014 · Sep 30, 2014 $1.28B
Total Liabilities FY 2014 · Jun 30, 2014 $1.42B
Total Liabilities FY 2014 · Mar 31, 2014 $1.4B
Total Liabilities restated FY 2014 · Dec 31, 2013 $1.21B
Total Liabilities FY 2014 · Sep 30, 2013 $1.03B
Total Liabilities FY 2014 · Jun 30, 2013 $974.88M
Total Liabilities FY 2014 · Mar 31, 2013 $930.59M
Current Assets restated FY 2014 · Dec 31, 2014 $254.55M
Current Assets FY 2014 · Sep 30, 2014 $324.45M
Current Assets FY 2014 · Jun 30, 2014 $201.09M
Current Assets FY 2014 · Mar 31, 2014 $192.21M
Current Assets restated FY 2014 · Dec 31, 2013 $154.74M
Current Assets FY 2014 · Sep 30, 2013 $148.11M
Current Assets FY 2014 · Jun 30, 2013 $117.54M
Current Assets FY 2014 · Mar 31, 2013 $119.58M
Total Assets restated FY 2014 · Dec 31, 2014 $1.15B
Total Assets FY 2014 · Sep 30, 2014 $1.2B
Total Assets FY 2014 · Jun 30, 2014 $1.13B
Total Assets FY 2014 · Mar 31, 2014 $1.31B
Total Assets restated FY 2014 · Dec 31, 2013 $1.13B
Total Assets FY 2014 · Sep 30, 2013 $970.09M
Total Assets FY 2014 · Jun 30, 2013 $952.81M
Total Assets FY 2014 · Mar 31, 2013 $927.7M
Sga Expense restated FY 2014 · Dec 31, 2014 $135.82M
Sga Expense FY 2014 · Sep 30, 2014 $37.92M
Sga Expense FY 2014 · Jun 30, 2014 $34.16M
Sga Expense FY 2014 · Mar 31, 2014 $30.19M
Sga Expense restated FY 2014 · Dec 31, 2013 $107.4M
Sga Expense FY 2014 · Sep 30, 2013 $25.21M
Sga Expense FY 2014 · Jun 30, 2013 $23.35M
Sga Expense FY 2014 · Mar 31, 2013 $20.92M
Sga Expense restated FY 2014 · Dec 31, 2012 $83.31M
Net Income restated FY 2014 · Dec 31, 2014 −$357.29M
Net Income restated FY 2014 · Sep 30, 2014 −$87.88M
Net Income restated FY 2014 · Jun 30, 2014 −$210.24M
Net Income restated FY 2014 · Mar 31, 2014 −$30.83M
Net Income restated FY 2014 · Dec 31, 2013 −$87.8M
Net Income restated FY 2014 · Sep 30, 2013 −$27.84M
Net Income restated FY 2014 · Jun 30, 2013 −$20.83M
Net Income restated FY 2014 · Mar 31, 2013 −$21.35M
Net Income restated FY 2014 · Dec 31, 2012 −$158.71M
Gross Profit restated FY 2014 · Dec 31, 2014 $295.77M
Gross Profit restated FY 2014 · Dec 31, 2013 $200.73M
Gross Profit restated FY 2014 · Dec 31, 2012 $209.34M
Cost Of Revenue restated FY 2014 · Dec 31, 2014 $744.3M
Cost Of Revenue restated FY 2014 · Dec 31, 2013 $532.2M
Cost Of Revenue restated FY 2014 · Dec 31, 2012 $483.7M
Stock Issued FY 2014 · Sep 26, 2014 385K sh